Fmr LLC Macrogenics Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Fmr LLC holds 10,316 shares of MGNX stock, worth $34,042. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,316

Previous 75,505 86.34%

Holding current value

$34,042

Previous $1.11 Million 96.13%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.31 - $18.51 $215,775 - $1.21 Million	-65,189 Reduced 86.34%	10,316 $43,000
Q1 2024 May 13, 2024	SELL	$9.77 - $21.47 $113,165 - $248,687	-11,583 Reduced 13.3%	75,505 $1.11 Million
Q4 2023 Feb 13, 2024	SELL	$4.48 - $10.11 $5,479 - $12,364	-1,223 Reduced 1.38%	87,088 $837,000
Q3 2023 Nov 13, 2023	SELL	$4.48 - $6.19 $4,901 - $6,771	-1,094 Reduced 1.22%	88,311 $411,000
Q2 2023 Aug 11, 2023	BUY	$4.62 - $7.54 $103,986 - $169,710	22,508 Added 33.65%	89,405 $478,000
Q1 2023 May 11, 2023	BUY	$4.82 - $7.24 $281,584 - $422,960	58,420 Added 689.16%	66,897 $479,000
Q4 2022 Feb 13, 2023	SELL	$3.34 - $6.98 $745,751 - $1.56 Million	-223,279 Reduced 96.34%	8,477 $56,000
Q3 2022 Nov 10, 2022	SELL	$3.01 - $5.22 $496,628 - $861,263	-164,993 Reduced 41.59%	231,756 $802,000
Q2 2022 Aug 12, 2022	SELL	$2.25 - $9.99 $1.07 Million - $4.76 Million	-476,939 Reduced 54.59%	396,749 $1.17 Million
Q1 2022 May 13, 2022	SELL	$8.12 - $16.9 $3.06 Million - $6.37 Million	-376,793 Reduced 30.13%	873,688 $7.7 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $6.34 Million - $8.72 Million	-398,554 Reduced 24.17%	1,250,481 $20.1 Million
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $5.03 Million - $7.31 Million	-254,836 Reduced 13.39%	1,649,035 $34.5 Million
Q2 2021 Aug 13, 2021	BUY	$20.49 - $35.63 $39 Million - $67.8 Million	1,903,871 New	1,903,871 $51.1 Million

Others Institutions Holding MGNX

# of Institutions

154

Shares Held

60.6M

Call Options Held

218K

Put Options Held

259K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $203M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account